Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Net Income (2018 - 2025)

Historic Net Income for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$59.1 million.

  • Bicycle Therapeutics' Net Income fell 1633.4% to -$59.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256.4 million, marking a year-over-year decrease of 5384.15%. This contributed to the annual value of -$174.8 million for FY2024, which is 348.97% up from last year.
  • Bicycle Therapeutics' Net Income amounted to -$59.1 million in Q3 2025, which was down 1633.4% from -$79.0 million recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' Net Income peaked at -$14.7 million during Q3 2021, and registered a low of -$79.0 million during Q2 2025.
  • Moreover, its 5-year median value for Net Income was -$39.1 million (2023), whereas its average is -$39.1 million.
  • In the last 5 years, Bicycle Therapeutics' Net Income surged by 3212.93% in 2024 and then plummeted by 12909.89% in 2025.
  • Over the past 5 years, Bicycle Therapeutics' Net Income (Quarter) stood at -$19.1 million in 2021, then tumbled by 94.02% to -$37.0 million in 2022, then plummeted by 34.01% to -$49.6 million in 2023, then fell by 16.31% to -$57.6 million in 2024, then fell by 2.52% to -$59.1 million in 2025.
  • Its last three reported values are -$59.1 million in Q3 2025, -$79.0 million for Q2 2025, and -$60.7 million during Q1 2025.